Read + Share
Amedeo Smart
Independent Medical Education
Lee JM, Annunziata CM, Hays JL, Cao L, et al. Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment. Gynecol Oncol 2020 Jul 31. pii: S0090-8258(20)33677.PMID: 32747013
Email
LinkedIn
Facebook
Twitter
Privacy Policy